|
| 36695047 | Lack of the human choline transporter-like protein SLC44A2 causes hearing impairment and a rare red blood phenotype. | EMBO Mol Med | 2023 |
| 34980629 | Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study. | BMJ Open | 2022 |
| 35579907 | Impact of Nodal Metastases in HPV-Negative Oropharyngeal Cancer. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35576195 | Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study. | PLoS One | 2022 |
| 35460939 | Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults. | Tumour Virus Res | 2022 |
| 35416374 | Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor. | Head Neck | 2022 |
| 35224804 | Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma. | Head Neck | 2022 |
| 33203919 | TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. | Mod Pathol | 2021 |
| 33891627 | Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study. | PLoS One | 2021 |
| 34579737 | Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma. | J Transl Med | 2021 |
| 34160069 | SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer. | Cancer | 2021 |
| 34371293 | Slc44a2 deletion alters tetraspanin and N-cadherin expression: Reduced adhesion and enhanced proliferation in cultured mesenchymal lung cells. | Tissue Cell | 2021 |
| 33073473 | Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma. | Head Neck | 2021 |
| 32406560 | Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer. | Head Neck | 2020 |
| 31874109 | HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. | J Clin Invest | 2020 |
| 31744898 | Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. | Mol Cancer Ther | 2020 |
| 32574978 | Characteristics of head and neck squamous cell carcinoma cell Lines reflect human tumor biology independent of primary etiologies and HPV status. | Transl Oncol | 2020 |
| 32933512 | Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis. | BMC Public Health | 2020 |
| 32954225 | Viral Integration Analysis Reveals Likely Common Clonal Origin of Bilateral HPV16-Positive, p16-Positive Tonsil Tumors. | Arch Clin Med Case Rep | 2020 |
| 30640567 | Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas. | Expert Rev Mol Diagn | 2019 |
| 31662358 | HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study. | BMJ Open | 2019 |
| 31238911 | HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women. | BMC Public Health | 2019 |
| 30775826 | Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma. | Head Neck | 2019 |
| 31090975 | The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel. | Head Neck | 2019 |
| 30858165 | Rationale for Using Irreversible Epidermal Growth Factor Receptor Inhibitors in Combination with Phosphatidylinositol 3-Kinase Inhibitors for Advanced Head and Neck Squamous Cell Carcinoma. | Mol Pharmacol | 2019 |
| 30765872 | Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for οNp63α. | Br J Cancer | 2019 |
| 30959071 | Multisite HPV infections in the United States (NHANES 2003-2014): An overview and synthesis. | Prev Med | 2019 |
| 30361882 | Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma. | Cancer Immunol Immunother | 2019 |
| 28928286 | HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers. | Mol Cancer Res | 2018 |
| 29805635 | Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis. | Oncol Lett | 2018 |
| 29978468 | DNA concentration from self samples for HPV testing. | Int J Cancer | 2018 |
| 30108165 | Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease. | Mol Cancer Res | 2018 |
| 30527230 | The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines. | Oral Oncol | 2018 |
| 30312801 | Characterization of hemostasis in mice lacking the novel thrombosis susceptibility gene Slc44a2. | Thromb Res | 2018 |
| 30282679 | Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study. | BMJ Open | 2018 |
| 30380422 | Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. | Cell Rep | 2018 |
| 29362132 | HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers. | Oral Oncol | 2018 |
| 29606294 | Retraction notice to: Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents. | Cancer Lett | 2018 |
| 29769207 | Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine. | Clin Cancer Res | 2018 |
| 29227715 | Human Papillomavirus Genome Integration and Head and Neck Cancer. | J Dent Res | 2018 |
| 29053175 | Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. | Cancer | 2018 |
| 29145573 | Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas. | Ann Oncol | 2018 |
| 28949800 | An Algorithm to Evaluate Suspected Lung Metastases in Patients with HPV-Associated Oropharyngeal Cancer. | Otolaryngol Head Neck Surg | 2018 |
| 28032719 | Minichromosome maintenance protein 7 and geminin expression: Prognostic value in laryngeal squamous cell carcinoma in patients treated with radiotherapy and cetuximab. | Head Neck | 2017 |
| 28438292 | Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. | Oral Oncol | 2017 |
| 28426373 | Immortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer Research. | J Clin Oncol | 2017 |
| 28236344 | Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. | Head Neck | 2017 |
| 29121598 | Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells. | Neoplasia | 2017 |
| 28945296 | Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma. | Head Neck | 2017 |
| 28616099 | Epigenetic silencing of <i>SALL3</i> is an independent predictor of poor survival in head and neck cancer. | Clin Epigenetics | 2017 |